According to the report, the global glycomics market is projected to grow at a CAGR of 11.2% between 2024 and 2032 reaching a value of approximate USD 4.1 billion by 2032. Aided by the burgeoning demand in biotechnological research and the rise in chronic diseases necessitating advanced therapeutics, the market is expected to grow significantly by 2032.
Glycomics, akin to genomics and proteomics, is the systematic study of all glycan structures of a given cell or organism. Glycans, or complex sugars, play a fundamental role in a myriad of biological processes, impacting cellular communication, inflammation, cancer progression, and pathogen recognition. With the realisation that glycans influence nearly every major disease, including cancer, infectious diseases, and inflammatory conditions, the glycomics field has gained immense traction in the biopharmaceutical industry.
The driving force behind the global glycomics market growth is the escalating emphasis on glycan-based biomarker development and the burgeoning field of personalised medicine. As researchers begin to unravel the intricate glycan patterns linked to specific diseases, there is a profound potential for diagnostics and therapeutics that could redefine treatment paradigms.
Research in glycomics has also opened avenues for novel biopharmaceuticals, leading to the emergence of glycoengineered drugs. The pharmaceutical industry, keen on exploring new frontiers, has shifted significant resources towards understanding glycosylation patterns and leveraging them for drug development, thereby boosting the glycomics market demand.
Another significant catalyst propelling the glycomics market is the advancing analytical and bioinformatics tools. With cutting-edge mass spectrometry techniques, high-throughput glycan analysis, and sophisticated software for glycan data interpretation, researchers can decode complex glycan structures with unprecedented precision. This surge in technological advancements has not only reduced the time for glycan analysis but has also amplified the depth and breadth of glycomic studies.
The cosmetics and personal care industry, too, is influencing the glycomics market outlook. Understanding the role of glycans in skin aging, hydration, and barrier function, cosmetic giants are investing in glycomics-driven research to formulate groundbreaking products that cater to diverse skin needs. This integration of glycomics into skincare science is a testament to its expansive potential beyond just biomedicine.
Furthermore, the role of glycomics in plant and agricultural science cannot be undermined. With plants having a rich repertoire of glycan structures, the agricultural sector is leveraging glycomics to understand plant physiology, plant-microbe interactions, and to develop crop varieties with improved resistance and yield.
Glycomics, akin to genomics and proteomics, is the systematic study of all glycan structures of a given cell or organism. Glycans, or complex sugars, play a fundamental role in a myriad of biological processes, impacting cellular communication, inflammation, cancer progression, and pathogen recognition. With the realisation that glycans influence nearly every major disease, including cancer, infectious diseases, and inflammatory conditions, the glycomics field has gained immense traction in the biopharmaceutical industry.
The driving force behind the global glycomics market growth is the escalating emphasis on glycan-based biomarker development and the burgeoning field of personalised medicine. As researchers begin to unravel the intricate glycan patterns linked to specific diseases, there is a profound potential for diagnostics and therapeutics that could redefine treatment paradigms.
Research in glycomics has also opened avenues for novel biopharmaceuticals, leading to the emergence of glycoengineered drugs. The pharmaceutical industry, keen on exploring new frontiers, has shifted significant resources towards understanding glycosylation patterns and leveraging them for drug development, thereby boosting the glycomics market demand.
Another significant catalyst propelling the glycomics market is the advancing analytical and bioinformatics tools. With cutting-edge mass spectrometry techniques, high-throughput glycan analysis, and sophisticated software for glycan data interpretation, researchers can decode complex glycan structures with unprecedented precision. This surge in technological advancements has not only reduced the time for glycan analysis but has also amplified the depth and breadth of glycomic studies.
The cosmetics and personal care industry, too, is influencing the glycomics market outlook. Understanding the role of glycans in skin aging, hydration, and barrier function, cosmetic giants are investing in glycomics-driven research to formulate groundbreaking products that cater to diverse skin needs. This integration of glycomics into skincare science is a testament to its expansive potential beyond just biomedicine.
Furthermore, the role of glycomics in plant and agricultural science cannot be undermined. With plants having a rich repertoire of glycan structures, the agricultural sector is leveraging glycomics to understand plant physiology, plant-microbe interactions, and to develop crop varieties with improved resistance and yield.
Market Segmentation
The market can be divided based on product, application, end-use, and region.Market Breakup by Product
- Enzymes
- Glycosidases
- Neuraminidases
- Glycosyltransferases
- Sialyltransferases
- Others
- Kits
- Glycan Labelling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
- Instruments
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array Systems
- Others
Market Breakup by Application
- Drug Discovery and Development
- Diagnostics
- Others
Market Breakup by End-Use
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organisations (CROs)
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global glycomics market. Some of the major players explored in the report are as follows:- Merck KGaA
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Others
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope4 Key Assumptions7 Industry Opportunities and Challenges11 Value Chain Analysis
3 Report Description
5 Executive Summary
6 Snapshot
8 Global Glycomics Market Analysis
9 Regional Analysis
10 Market Dynamics
12 Competitive Landscape
13 Industry Events and Developments
1 Manufacturing Process
2 Project Requirement and Cost Analysis
List of Key Figures and Tables
Companies Mentioned
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Agilent Technologies Inc.
- Takara Bio Inc.
Methodology
LOADING...
